Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia

Blood. 1988 Aug;72(2):823-6.

Abstract

The effects of recombinant interleukin-6 (IL-6) on the proliferation of blast precursors present in the peripheral blood of patients with acute myeloblastic leukemia (AML) was investigated. IL-6 had little effect by itself; however, it synergized with granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) in the stimulation of AML blast colony formation. Responsiveness of blast progenitors to IL-6 was heterogeneous. On normal bone marrow cells the same synergy was observed on granulocyte and monocyte precursors (GM-CFC), while there was no significant effect on erythroid and multipotential precursors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Division / drug effects
  • Colony-Stimulating Factors / pharmacology
  • Drug Synergism
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Growth Substances / pharmacology
  • Humans
  • Interleukin-3 / pharmacology
  • Interleukin-6
  • Interleukins / pharmacology*
  • Leukemia, Myeloid, Acute / pathology*

Substances

  • Colony-Stimulating Factors
  • Growth Substances
  • Interleukin-3
  • Interleukin-6
  • Interleukins
  • Granulocyte-Macrophage Colony-Stimulating Factor